Chen, M., Mashima, T., Oishi, T., Muramatsu, Y., Seto, Y., Takamatsu, M., Kawata, N., Morino, S., Nakamura, A., Inaba, S., Yuan, X., Maruyama, K., Suzuki, M., Sato, A., Yoshida, H., Jang, M. K., Mizutani, A., Takeuch, K., Yamaguchi, K., Shirai, F., Nagayama, S., Katayama, R. and Seimiya, H.
Kondo, N., Utsumi, T., Shimizu, Y., Takemoto, A., Oh-Hara, T., Uchibori, K., Subat-Motoshi, S., Ninomiya, H., Takeuchi, K., Nishio, M., Miyazaki, Y. and Katayama, R.
MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF. JCI insight, in press (2023)
Yoshida, T., Kumagai, T., Toyozawa, R., Katayama, R., Nishio, M., Seto, T., Goto, K., Yamamoto, N., Ohe, Y., Kudou, K., Asato, T., Zhang, P. and Nakagawa, K.